Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SK-216 is a specific PAI-1 inhibitor. SK-216 reduced the extent of angiogenesis in the tumors and inhibited VEGF-induced migration and tube formation by human umbilical vein endothelial cells in vitro. SK-216 reduced the degree of bleomycin-induced pulmonary fibrosis in mice.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
10 mg | 35 days | $ 583.00 |
Description | SK-216 is a specific PAI-1 inhibitor. SK-216 reduced the extent of angiogenesis in the tumors and inhibited VEGF-induced migration and tube formation by human umbilical vein endothelial cells in vitro. SK-216 reduced the degree of bleomycin-induced pulmonary fibrosis in mice. |
Synonyms | SK216.Plasminogen activator inhibitor-1 (PAI-1) inhibitor |
Molecular Weight | 535.548 |
Formula | C29H31NNa2O6 |
CAS No. | 654080-03-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
SK-216 654080-03-2 SK216 SK216.Plasminogen activator inhibitor-1 (PAI-1) inhibitor SK 216 inhibitor inhibit